Suppr超能文献

二氧化碳描记法在微创表面活性剂给药中用于导管定位确认。

Capnography for catheter location confirmation in minimally invasive surfactant administration.

机构信息

Shaare Zedek Medical Center, Jerusalem, Israel.

Department of Pediatrics, Hebrew University of Jerusalem Medical School, Jerusalem, Israel.

出版信息

J Perinatol. 2023 Mar;43(3):300-304. doi: 10.1038/s41372-023-01624-5. Epub 2023 Jan 31.

Abstract

OBJECTIVES

Minimally Invasive Surfactant Treatment (MIST) is a common method for administering surfactant as a treatment for respiratory distress syndrome. However, tracheal catheter placement can be difficult to confirm. We assessed the presence of carbon dioxide (CO) in tracheal and esophageal gas aspirated using CO detector.

STUDY DESIGN

Retrospective arm: 20 infants, MIST catheter placement was assessed with a CO detector in two techniques and confirmed with clinical response. Prospective arm-10 infants, aimed to check for CO presence in aspirated esophageal gas during routine nasogastric tube insertion.

RESULTS

Retrospective arm: All infants had positive capnography. One infant that had no clinical response to MIST was diagnosed with total anomalous pulmonary venous return. All 10 infants of the prospective arm had a Negative capnography (P < 0.001, Fisher's exact test).

CONCLUSIONS

Readily available CO detectors can distinguish between tracheal and esophageal placement of MIST catheters prior to MIST.

摘要

目的

微创表面活性剂治疗(MIST)是一种常见的表面活性剂给药方法,用于治疗呼吸窘迫综合征。然而,气管导管的位置确认可能具有一定难度。我们使用二氧化碳(CO)探测器来评估从气管和食管抽吸气体中 CO 的存在。

研究设计

回顾性组:20 名婴儿,使用 CO 探测器评估两种技术中的 MIST 导管位置,并通过临床反应进行确认。前瞻性组 1-10 名婴儿,旨在检查常规鼻胃管插入过程中从食管抽吸气体中 CO 的存在。

结果

回顾性组:所有婴儿的呼气末二氧化碳描记图均为阳性。1 名对 MIST 无临床反应的婴儿被诊断为完全性肺静脉异常回流。前瞻性组的 10 名婴儿的呼气末二氧化碳描记图均为阴性(P < 0.001,Fisher 确切检验)。

结论

现成的 CO 探测器可在 MIST 之前区分 MIST 导管的气管和食管位置。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验